Founder built xHeal from illness

A systems architect turned his own chronic prostatitis tracking into xHeal, a health app that says it can warn users about flare-ups before symptoms hit. (xheal.ai) xHeal says it combines medical records, lab results, wearable data, and daily logs into a “Digital Twin” that tracks more than 250 health parameters and flags changes from a user’s baseline. The company’s site says the product launched in the United States on September 29, 2025, and reached its first 1,000 users outside alpha and beta testing by December 1, 2025. (xheal.ai, xheal.ai) The company also says its predictive models and “AI-generated diagnostics” were tested on about 5,000 volunteer patient cases in July 2025 and reached 95% accuracy against confirmed diagnoses. xHeal’s public materials do not publish a peer-reviewed validation study or the underlying methodology for that figure. (xheal.ai) Chronic prostatitis, often grouped with chronic pelvic pain syndrome, is a long-lasting pain condition with widely varying symptoms and no single straightforward treatment path. The American Urological Association’s 2025 guideline says that variability makes management difficult and often multidisciplinary. (auanet.org) That is the problem xHeal is built around: symptoms that change over time, data scattered across devices and hospitals, and short specialist visits that make pattern-finding hard. The app’s pitch is that combining sleep, stress, activity, labs, medications, and symptom logs can surface warning signs earlier than any one data source alone. (xheal.ai, xheal.ai) The company frames the product as a consumer health companion rather than a diagnostic device. Its App Store listing describes xHeal as a “Lifestyle & Wellness Companion,” says it is available for iPhone, and lists xHeal Corp as the developer. (apple.com) xHeal’s own case studies center on founder-led self-tracking. One company post says the system suggested checking HOMA-IR, a lab measure linked to insulin resistance, during beta testing; another says the app is designed to detect “24 to 48 hours” of pre-flare signals in wearable and symptom data. (xheal.ai, xheal.ai) The startup is still small. xHeal says it was incorporated in Florida on June 6, 2025, later joined Amazon Web Services’ startup credits program, and launched version 2 in Europe and the United States on January 19, 2026. (xheal.ai) What xHeal has published so far reads less like a clinical trial dossier than a founder’s operating log: collect every signal, test it on yourself, then productize the workflow for other patients with messy chronic conditions. (xheal.ai, xheal.ai)